AEROGENTM is a highly successful company that has developed a patented vibrating mesh technology for nebulisers, and has established itself as the global market leader in acute care drug delivery for ventilated patients.
AEROGENTM derives a competitive advantage from a formidable patent portfolio of 14 patent families which bring financial and business support benefits in a competitive environment. “We work from a 60% gross margin platform and our strong IP position affords this, which is at a considerable premium to our competitors,” says Brandan Hogan, Senior VP of Engineering. The patents support perceptions of a unique and technically superior product by customers and investors. The patent portfolio is a valuable marketing took for promoting integrity, confidence, and the uniqueness of its technology and products.
AEROGENTM has grown through a merger, listing on the NASDAQ and finally a management buyout. The patent portfolio proved to be a valuable asset at each phase of the company’s growth and today it underpins company performance.